November 22, 2011
Heparinex, L.L.C. Awarded $1.6 Million EDGE Fund Endowment To Enable Chemistry, Manufacturing and Controls For Its Heparosan Proprietary Drug Delivery Technology
February 3, 2009
Heparinex, L.L.C. Chief Scientist Dr. Paul DeAngelis Receives OCAST Research Funding Award
January 25, 2007
Chief Scientist Named OU College of Medicine Research Scholar
for Emergent Technologies news.
Visit related companies
Technologies, Inc., Hyalose
Pure Protein, L.L.C.
©2009 Heparinex, L.L.C.. All rights reserved. Please read our Privacy
Policy. Contact Us.